Todos Med (OTCMKTS:TOMDF) & Performant Healthcare (NASDAQ:PHLT) Critical Comparison

Todos Med (OTCMKTS:TOMDF) and Performant Healthcare (NASDAQ:PHLT) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, valuation, risk, analyst recommendations and dividends.

Insider & Institutional Ownership

77.2% of Performant Healthcare shares are owned by institutional investors. 9.1% of Performant Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Todos Med and Performant Healthcare”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Todos Med	N/A	N/A	N/A	N/A	N/A
Performant Healthcare	$122.98 million	4.90	-$9.90 million	($0.01)	-763.00

Todos Med has higher earnings, but lower revenue than Performant Healthcare.

Analyst Ratings

This is a summary of current recommendations and price targets for Todos Med and Performant Healthcare, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Todos Med	0	0	0	0	0.00
Performant Healthcare	0	4	1	0	2.20

Performant Healthcare has a consensus target price of $7.88, suggesting a potential upside of 3.21%. Given Performant Healthcare’s stronger consensus rating and higher probable upside, analysts plainly believe Performant Healthcare is more favorable than Todos Med.

Profitability

This table compares Todos Med and Performant Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Todos Med	N/A	N/A	N/A
Performant Healthcare	-0.64%	-0.04%	-0.03%

Risk & Volatility

Todos Med has a beta of -0.01, suggesting that its share price is 101% less volatile than the S&P 500. Comparatively, Performant Healthcare has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500.

Summary

Performant Healthcare beats Todos Med on 7 of the 10 factors compared between the two stocks.

About Todos Med

Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.

About Performant Healthcare

Performant Healthcare, Inc. engages in the provision of technology-enabled audit, recovery, customer care, and related analytics services. Its services help identify improper payments, and in some markets, restructure and recover delinquent or defaulted assets and improper payments for both government and private clients. The company was founded in 1976 and is headquartered in Plantation, FL.